π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Subjects with perennial allergic rhinitis will be randomized to 320 mcg of ...
Status
Completed
Location
Teva Clinical Sudy Site
Start Date
2009-10-31
Trial ID
NCT00988247
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of an invest...
Status
Completed
Location
Teva Clinical Study Site
Start Date
2011-03
Trial ID
NCT01307319
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled parallel-group study...
Status
Completed
Location
Teva Investigational Site 12813
Start Date
2013-12-26
Trial ID
NCT02040779
The purpose of the study is to assess the efficacy and safety of an investi...
Status
Completed
Location
Teva Clinical Trial Site
Start Date
2009-12-31
Trial ID
NCT01024608
Treatments Being Tested
This is a phase 2, randomized, double-blind, placebo-controlled, parallel-g...
Status
Completed
Location
Teva Global Respiratory Research Study Site
Start Date
2009-03
Trial ID
NCT00854360
Treatments Being Tested
The purpose of this study is to assess the effect of one of five possible s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01615874
The purpose of the study is to assess the efficacy and safety of an investi...
Status
Completed
Location
Teva Clinical Study Site
Start Date
2010-05
Trial ID
NCT01134705
Treatments Being Tested
The purpose of the study is to evaluate the effects of BDP HFA Nasal Aeroso...
Status
Completed
Location
Teva Clinical Study Site
Start Date
2010-06
Trial ID
NCT01133626
This randomized, double-blind, double-dummy, placebo-controlled, parallel-g...
Status
Completed
Location
Teva Investigational Site 12346
Start Date
2013-12
Trial ID
NCT02040766